default author photo

Kumar Prabhash

Tata Memorial Centre - Tata Memorial Hospital

India

SCHOLARLY PAPERS

5

DOWNLOADS

433

TOTAL CITATIONS

0

Scholarly Papers (5)

1.

IPSOS: A Phase III, Global, Multicentre, Open-Label, Randomised, Controlled Study of First-Line Atezolizumab Versus Single-Agent Chemotherapy in Patients with Non-Small Cell Lung Cancer Ineligible for Treatment with a Platinum-Containing Regimen

Number of pages: 46 Posted: 27 Dec 2022
Cancer Research UK Lung Cancer Centre of Excellence, University Hospital Regensburg, Tata Memorial Centre - Tata Memorial Hospital, Maria Sklodowska-Curie National Research Institute of Oncology, Mazowieckie Centrum Leczenia Chorób Płuc i Gruźlicy, Shanghai Jiao Tong University (SJTU) - Shanghai Chest Hospital, LKI Lungenfachklinik Immenhausen, Royal Cornwall Hospitals NHS Trust, Hospital Universitario Virgen Macarena, The University of Manchester - Division of Cancer Sciences, ASST - Monza - San Gerardo Hospital, Cho Ray Hospital - Cho Ray Cancer Centre, Tianjin Medical University - Tianjin Cancer Institute, University of Toronto - Princess Margaret Cancer Centre, IRCCS Regina Elena National Cancer Institute, Oncologico Potosino, San Luis Potosi, German Centre for Lung Research - Lungen Clinic Grosshansdorf, Hospital Duran i Reynals (ICO) - Catalan Institute of Oncology, University of São Paulo (USP) - Instituto do Cancer do Estado de Sao Paulo, F Hoffmann-La Roche Ltd, F Hoffmann-La Roche Ltd, F Hoffmann-La Roche Ltd, Genentech, Inc. - San Francisco, F Hoffmann-La Roche Ltd, F Hoffmann-La Roche Ltd and Centre Hospitalier Universitaire Vaudois (CHUV)
Downloads 130 (558,171)

Abstract:

Loading...

atezolizumab, PD-L1 inhibitor, IPSOS, elderly, Eastern Cooperative Oncology Group performance status (ECOG PS), non-small cell lung cancer (NSCLC), phase III, overall survival, chemotherapy, first-line, gemcitabine, vinorelbine, platinum-ineligible

2.

Patient Selection and Outcomes in Reirradiation for Head and Neck Cancers: A Prospective Cohort Study

Number of pages: 27 Posted: 08 Jul 2024
Tata Memorial Centre, Tata Memorial Centre, Tata Memorial Centre, Tata Memorial Centre - Tata Memorial Hospital, Tata Memorial Centre, Tata Memorial Centre - Tata Memorial Hospital, Tata Memorial Centre - Tata Memorial Hospital, Tata Memorial Centre, Tata Memorial Centre, Tata Memorial Centre, Tata Memorial Centre, Tata Memorial Centre, Tata Memorial Centre, Tata Memorial Centre, Tata Memorial Centre - Tata Memorial Hospital, Tata Memorial Centre - Department of Head & Neck Oncology, Tata Memorial Centre, Tata Memorial Centre - Tata Memorial Hospital, Tata Memorial Centre, Tata Memorial Centre - Tata Memorial Hospital, Tata Memorial Centre, Tata Memorial Centre, Tata Memorial Centre, Tata Memorial Centre, Tata Memorial Centre - Tata Memorial Hospital, Tata Memorial Centre - Department of Medical Oncology, Tata Memorial Centre - Tata Memorial Hospital, Tata Memorial Centre - Department of Medical Oncology and Tata Memorial Centre
Downloads 115 (617,542)

Abstract:

Loading...

Reirradiation, Head and Neck Cancers, Patient selection, Outcomes, Toxicities

3.

Thra Mutations as Promoters of Cellular Plasticity in Anaplastic Thyroid Cancer

Number of pages: 32 Posted: 12 Jun 2024
Tata Memorial Centre, Tata Memorial Centre - Department of Medical Oncology, Tata Memorial Centre - Tata Memorial Hospital, Tata Memorial Centre, Tata Memorial Centre - Tata Memorial Hospital, Tata Memorial Centre - Tata Memorial Hospital, Tata Memorial Centre, Tata Memorial Centre - Tata Memorial Hospital, Tata Memorial Centre - Tata Memorial Hospital, Tata Memorial Centre - Department of Medical Oncology, Tata Memorial Centre - Department of Medical Oncology, Tata Memorial Centre, Tata Memorial Centre, affiliation not provided to SSRN and Tata Memorial Centre - Tata Memorial Hospital
Downloads 107 (654,668)

Abstract:

Loading...

Anaplastic thyroid cancer, THRA mutations, lineage plasticity, exome sequencing

4.

Presentation and Outcomes of Second Primary Malignancies (Spms) in Locally Advanced Oral Cavity Squamous Carcinoma (La-Oscc): Secondary Analysis of a Phase Iii Randomised Control Trial (Nct00193843)

Number of pages: 24 Posted: 24 Sep 2024
Tata Memorial Centre, Tata Memorial Centre - Tata Memorial Hospital, Tata Memorial Centre, Tata Memorial Centre - Tata Memorial Hospital, affiliation not provided to SSRN, Tata Memorial Centre, Tata Memorial Centre - Tata Memorial Hospital, Tata Memorial Centre - Department of Radiation Oncology, Tata Memorial Centre, Tata Memorial Centre, Tata Memorial Centre, Tata Memorial Centre, Tata Memorial Centre, Tata Memorial Centre - Tata Memorial Hospital, Tata Memorial Centre - Tata Memorial Hospital, Tata Memorial Centre, Tata Memorial Centre - Department of Head & Neck Oncology, Tata Memorial Centre, affiliation not provided to SSRN, Tata Memorial Centre - Tata Memorial Hospital, Tata Memorial Centre - Department of Medical Oncology, Tata Memorial Centre - Tata Memorial Hospital and affiliation not provided to SSRN
Downloads 65 (916,100)

Abstract:

Loading...

Radiotherapy, Second Primary Cancer, Oral Cavity Cancer, Head Neck Cancer

5.

Real World Experience with Hippocampal Avoidance Whole Brain Radiotherapy with Simultaneous Integrated Boost for Brain Metastases

Number of pages: 18 Posted: 13 May 2026
Tata Memorial Centre - Tata Memorial Hospital, Tata Memorial Centre - Tata Memorial Hospital, Tata Memorial Centre - Tata Memorial Hospital, Tata Memorial Centre - Department of Medical Oncology, Tata Memorial Centre - Tata Memorial Hospital, Tata Memorial Centre - Tata Memorial Hospital, Tata Memorial Centre, Tata Memorial Centre - Tata Memorial Hospital, Tata Memorial Centre - Tata Memorial Hospital, Tata Memorial Centre - Tata Memorial Hospital and Tata Memorial Centre - Tata Memorial Hospital
Downloads 16 (1,518,554)

Abstract:

Loading...

brain metastases, hippocampal-avoidance, WBRT, simultaneous integrated boost, NSCLC